Effect of intervention timing of CRT combined with third generation EGFR-TKIs in EGFR-mutant NSCLC.

被引：0
|
作者：
Deng, Guangchuan [1 ]
Li, Zhenxiang [1 ]
机构：
[1] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Peoples R China
来源：
RADIOTHERAPY AND ONCOLOGY | 2024年 / 194卷
关键词：
EGFR-mutant; Lung adenocarcinoma; Brain metastasis;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2307
引用
收藏
页码：S1732 / S1734
页数：4
相关论文
共 50 条
  • [1] Effect of intervention timing of CRT combined non-third generation EGFR-TKIs in EGFR-mutant NSCLC
    Deng, Guangchuan
    Li, Zhenxiang
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S1729 - S1730
  • [2] Tamoxifen Might Enhance the Effect of EGFR-TKIs on EGFR-Mutant NSCLC Cells
    He, Y.
    Zhang, Q.
    Zheng, M.
    Chen, Z.
    Wei, X.
    Yang, X.
    Gao, X.
    Wu, Y.
    Liu, S.
    Zhou, Q.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S242 - S242
  • [3] Combination of EGFR-TKIs with Chemotherapy versus EGFR-TKIs alone in EGFR-Mutant Advanced NSCLC with Concomitant Genetic Alterations
    Feng, W.
    Gu, W.
    Zhang, H.
    Lu, Y.
    Gu, W.
    Li, M.
    Yang, S.
    Zhang, J.
    Ye, Z.
    Lin, Q.
    Liang, Y.
    Chen, H.
    Cheng, Y.
    Yao, M.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S622 - S622
  • [4] Postoperative adjuvant EGFR-TKIs for resected EGFR-mutant NSCLC-opportunities and obstacles
    Parris, Brielle A.
    Leong, Steven
    Marshall, Henry
    Yang, Ian A.
    Bowman, Rayleen V.
    Fong, Kwun M.
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (07)
  • [5] EGFR-TKIs Combined Hydroxycamptothecin Improved Outcomes in EGFR-Mutant NSCLC Patients Who Harboring Pericardial Effusion
    Wang, X.
    Yao, J.
    Guo, R.
    Lu, X.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S985 - S985
  • [6] EGFR-TKIs plus bevacizumab demonstrated survival benefit than EGFR-TKIs alone in EGFR-mutant NSCLC patients with multiple brain metastases
    Jiang, T.
    Zhou, C.
    ANNALS OF ONCOLOGY, 2019, 30
  • [7] EGFR-TKIs plus bevacizumab demonstrated survival benefit than EGFR-TKIs alone in patients with EGFR-mutant NSCLC and multiple brain metastases
    Jiang, Tao
    Zhang, Yongchang
    Li, Xuefei
    Zhao, Chao
    Chen, Xiaoxia
    Su, Chunxia
    Ren, Shengxiang
    Yang, Nong
    Zhou, Caicun
    EUROPEAN JOURNAL OF CANCER, 2019, 121 : 98 - 108
  • [8] The Usefulness of Liquid Biopsy for ctDNA in Patients with EGFR-Mutant NSCLC During and After Treatment with EGFR-TKIs
    Yokoyama, T.
    Naka, G.
    Ishida, H.
    Kishi, K.
    Ohashi, Y.
    Kunitoh, H.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2223 - S2223
  • [9] Effect of EGFR-TKIs Combined with Cerebral Radiotherapy on Prognosis of Patients with EGFR-Mutant Lung Adenocarcinoma with Brain Metastasis
    Deng, G.
    Li, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : S164 - S164
  • [10] Clonal dominance of EGFR and efficacy of EGFR-tyrosine kinase inhibitors (EGFR-TKIs) in NSCLC.
    Ai, Xinghao
    Chen, Rongrong
    Cui, Jiuwei
    Zhang, Jiexia
    Lin, Wen
    Xie, Congying
    Hu, Xiaohua
    Zhang, Junping
    Jiao, Xiaodong
    Rao, Chuangzhou
    Yang, Weihua
    Chang, Lianpeng
    Xia, Xuefeng
    Yi, Xin
    Lu, Shun
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345